Figure 8.
Validation of the EIF2AK3 expression in glioma tissues and non-tumor tissue analyzed through RT-qPCR and IHC. (A) The mRNA expression level of EIF2AK3 in diffuse glioma with glioma and para-carcinoma tissues via RT-qPCR. (B) The mRNA expression level of EIF2AK3 in different grades of glioma samples via RT-qPCR. (C) The protein expression level of EIF2AK3 in diffuse glioma specimens with different grades has been analyzed via IHC staining. ns, P > 0.05; *P < 0.05; ***P < 0.001.